At #EUROPCR 2025, Nilesh Pareek and Thomas Keeble explore how NIRS IVUS is transforming plaque assessment and PCI planning. This dual-modality system from NIPRO combines high-quality intravascular ultrasound with near-infrared spectroscopy (NRIS) to detect and visualise lipid-rich plaques. The technology provides both a colour-coded map and a Lipid Core Burden Index (LCBI) score, offering a precise measure of plaque vulnerability. In this conversation, they share how NIRS IVUS integrates naturally into cathlab workflows, helps tailor treatment strategies for culprit and non-culprit lesions, and opens new possibilities for personalising care based on plaque characteristics. Supported by NIPRO.
NIRS + IVUS in practice: How dual imaging is shaping precision PCI
A 6-minute clinical conversation recorded at EuroPCR 2025
What if you could see plaque vulnerability, not just vessel structure?
At EuroPCR 2025, Dr. Thomas Keeble (CTC Essex) and Dr. Nilesh Pareek (King’s College London) shared their hands-on experience with a powerful imaging combo: Intravascular Ultrasound (IVUS) + Near-Infrared Spectroscopy (NIRS).
Powered by Makoto from NIPRO, this dual-modality system offers:
- Real-time visualisation of lipid-rich plaques (via colour-coded NIRS mapping)
- A quantifiable measure of plaque burden (Lipid Core Burden Index, LCBI)
- Seamless integration into cathlab workflows
- Better treatment planning for both culprit and non-culprit lesions
In this 6-minute exchange, the two experts deliver what many call an elevator pitch for imaging-guided PCI, concise, clinical, and actionable.
Why it matters
- Go beyond the angiogram with plaque composition insight
- Improve lesion assessment and risk stratification
- Support decisions with data, not assumptions
Makoto™ Intravascular Imaging System
With this revolutionary product, we are able to help cardiologists predict and prevent heart attacks, -and are committed to supporting you every step of the way.
